Patent · US Active

Oligonucleotides associated with antibodies

US11661631B2 · kind B2 · utility

0Cited by
209References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 21, 2020
Grant dateMay 30, 2023
Priority date
Expiry dateJan 30, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2563/185
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed herein include systems, methods, compositions, and kits for determining protein expression and gene expression simultaneously and for sample indexing. In some embodiments, an oligonucleotide associated with a cellular component-binding reagent (e.g., an antibody) comprises one or more of a unique molecular label sequence, a primer adapter, antibody-specific barcode sequence, an alignment sequence, and/or a poly(A) sequence. In some embodiments, the oligonucleotide is associated with the cellular component-binding reagent via a linker (e.g., 5AmMC12).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.